Literature DB >> 7775890

An audit of caesarean section among Saudi females in Jeddah, Saudi Arabia.

B I Elhag1, W A Milaat, E R Taylouni.   

Abstract

In this study the case records of 1414 patients who delivered at Alshaty hospital within one year were examined and some important variables related to caesarean section cases and their outcome were discussed. The caesarean section rate was found to be 9.9%. The high number of grand multigravida and primigravida among these Saudi mothers have contributed to this high caesarean section rate. The high emergencies in these sections (73.6%) have resulted in higher incidence of maternal and fetal morbidity namely postoperative pyrexia (37%), maternal anemia (20%) and extensive neonatal resuscitation (34%). The main indications of caesarean section in this hospital were repeated caesarean section (34.3%), failure of progress (19.3%) and fetal distress 12.9%. The relation and interaction between the three groups were thoroughly discussed based on the mechanisms of these indications. It is concluded that the changing trend of indications of caesarean section was mostly related to the change in departmental management rather than change in the characteristics of the patients.

Entities:  

Keywords:  Arab Countries; Asia; Cesarean Section--determinants; Clinical Research; Delivery; Demographic Factors; Developing Countries; Diseases; Morbidity; Mortality; Obstetrical Surgery; Population; Population Dynamics; Pregnancy; Pregnancy Outcomes; Reproduction; Research Methodology; Research Report; Saudi Arabia; Surgery; Treatment; Western Asia

Mesh:

Year:  1994        PMID: 7775890

Source DB:  PubMed          Journal:  J Egypt Public Health Assoc        ISSN: 0013-2446


  2 in total

1.  Hospital-based caesarean section in the Arab region: an overview.

Authors:  M Khawaja; N Choueiry; R Jurdi
Journal:  East Mediterr Health J       Date:  2009 Mar-Apr       Impact factor: 1.628

2.  Caesarean section rates in the Arab region: a cross-national study.

Authors:  Rozzet Jurdi; Marwan Khawaja
Journal:  Health Policy Plan       Date:  2004-03       Impact factor: 3.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.